FDA approves injectable foam for varicose veins

12/3/2013 | Reuters · MedPage Today (free registration)

The FDA has approved British drugmaker BTG's Varithena, formerly called Varisolve, which is an injectable foam for varicose veins, the company announced. FDA approval had been delayed due to concerns about the product's effects if it enters the bloodstream.

View Full Article in:

Reuters · MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR